Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: Double-blind, randomized trial in the Islamic Republic of Iran

Bulletin of the World Health Organization

Volumn 81, Issue 5, 2003, Pages 353-359

  Asilian, A ^a   Jalayer, T ^a   Nilforooshzadeh, M ^a   Ghassemi, R L ^a   Peto, R ^b   Wayling, S ^c   Olliaro, P ^c   Modabber, F ^c,d  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b CLINICAL TRIAL SERVICE UNIT   (United Kingdom)

^c WORLD BANK   (United States)

^d INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

Author keywords

Administration, Cutaneous; Comparative study; Cutaneous drug therapy; Double blind method; Iran; Leishmaniasis; Ointments administration and dosage; Paromomycin therapeutic use administration and dosage; Randomized controlled trials; Treatment outcome

Indexed keywords

PAROMOMYCIN; PLACEBO;

DISEASE TREATMENT; DRUG PRESCRIBING; LEISHMANIASIS;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPITHELIZATION; FEMALE; HUMAN; IRAN; LEISHMANIA MAJOR; MAJOR CLINICAL STUDY; MALE; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN LEISHMANIASIS; TREATMENT OUTCOME;

ANTIPROTOZOAL AGENTS; CHILD; DOUBLE-BLIND METHOD; HUMANS; IRAN; LEISHMANIASIS, CUTANEOUS; OINTMENTS; PAROMOMYCIN; TREATMENT OUTCOME;

IRAN;

EID: 0037677957     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Desjeux P. Leishmaniasis: public health aspects and control. In: Dowlati Y, Modabber F, editors. Clinics in dermatology. New York: Elsevier; 1996. p. 417-23.
2. Nadim A. Current situation with regard to leishmaniasis in the countries of the eastern Mediterranean Region: an overview. In: Walton BC, Wijeyaratna PM, Modabber F, editors. Research on control strategies for leishmaniasis. Toronto: IDRC; 1988. p. 162-8.
3. Gamier T, Croft SL. Topical treatment for cutaneous leishmaniasis. Current Opinion in Investigational Drugs 2002;3:538-44.
4. El-On J, Jacobs GP, Witzum E, Greenblatt CL. Development of topical treatment for cutaneous leishmaniasis caused by L. major in experimental animals. Antimicrobial Agents and Chemotherapy 1984;26:745-51.
5. Neal RA, Murphy AG, Olliaro P, Croft S. Aminosidine ointments for the treatment of experimental leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 1994;88:223-5.
6. Neal RA, Allen S, McCoy N, Olliaro P, Croft SL. The sensitivity of Leishmania species to aminosidine. Journal of Antimicrobial Chemotherapy 1995;35:577-84.
7. El-On J, Jacobs GP, Weinrauch L. Topical chemotherapy of cutaneous leishmaniasis. Parasitology Today 1987;41:76-81.
8. El-Safi SH, Murphy AG, Bryceson ADM, Neal RA. A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment. Transactions of the Royal Society of Tropical Medicine and Hygiene 1990;84:690-1.
9. El-On J, Halevy S, Grunwald MH, Weinrauch L. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind study. Journal of the American Academy of Dermatology 1992;27:227-31.
10. Soto J, Fuya P, Herrera R, Berman J. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimoniate as treatment for American cutaneous leishmaniasis: a controlled study. Clinical Infectious Diseases 1998;26:56-8.
11. Neva FA, Ponce C, Ponce E, Kreutzer R, Modabber F, Olliaro P. Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin. Transactions of the Royal Society of Tropical Medicine and Hygiene 1997;91:473-5.
12. Arana BA, Mendoza CE, Rizzo NR, Kroeger A. Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala. American Journal of Tropical Medicine and Hygiene 2001;65:466-70.
13. Bryceson ADM, Murphy A. Treatment of cutaneous leishmaniasis of the Old World with aminosidine ointment: results of an open study in patients in London. Transactions of the Royal Society of Tropical Medicine and Hygiene 1994;88:226-8.
14. Ben Salah A, Zakraoui H, Zaatour A, Ftaiti A, Zaafouri B, Ahmadi Z, et al. A randomised placebo-controlled trial in Tunisia of treating cutaneous leishmaniasis with paromomycin ointment. American Journal of Tropical Medicine and Hygiene 1995;53:162-6.
15. Asilian A, Jalayer T, Withworth J, Ghasemi RL, Nilforooshzadeh M, Olliaro P. A randomised placebo-controlled trial of a two week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis. American Journal of Tropical Medicine and Hygiene 1995;53:648-51.